[Federal Register Volume 79, Number 70 (Friday, April 11, 2014)]
[Notices]
[Pages 20216-20217]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-08079]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Discretionary Advisory Committee on Heritable Disorders in 
Newborns and Children; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463, codified at 5 U.S.C. App.), notice is 
hereby given of the following meeting:

    Name: Discretionary Advisory Committee on Heritable Disorders in 
Newborns and Children.
    Dates and Times: May 29, 2014, 9:30 a.m. to 4:30 p.m. May 30, 
2014, 9:30 a.m. to 3:00 p.m.
    Place: Webinar and In-Person, U.S. Pharmacopeial Convention 
(USP) Headquarters, 12601 Twinbrook Parkway, Rockville, Maryland 
20852.
    Status: The meeting will be open to the public with attendance 
limited to space availability. Participants also have the option of 
viewing the meeting via webinar. Whether attending in-person or via 
webinar, all participants must register for the meeting at https://www.blsmeetings.net/ACHDNCMay2014. The registration deadline is 
Friday, May 2, 2014, 11:59 p.m. Eastern Time. If there are technical 
problems gaining access to the Web site, please contact Anthony 
Rodell, Director of Client Relations, at 
[email protected].
    Purpose: The Discretionary Advisory Committee on Heritable 
Disorders in Newborns and Children (Committee), as authorized by 
Public Health Service Act (PHS), 42 U.S.C. 217a: Advisory councils 
or committees, was established to advise the Secretary of the 
Department of Health and Human Services about the development of 
newborn screening activities, technologies, policies, guidelines, 
and programs for effectively reducing morbidity and mortality in 
newborns and children having, or at risk for, heritable disorders. 
Note: the Committee's recommendations regarding additional 
conditions/inherited disorders for screening that have been adopted 
by the Secretary are included in the Recommended Uniform Screening 
Panel and constitute part of the comprehensive guidelines supported 
by the Health Resources and Services Administration (HRSA). Pursuant 
to section 2713 of the Public Health Service Act, codified at 42 
U.S.C. 300gg-13, non-grandfathered health plans are required to 
cover screenings included in the HRSA-supported comprehensive 
guidelines without charging a co-payment, co-insurance, or 
deductible for plan years (i.e., policy years) beginning on or after 
the date that is 1 year from the Secretary's adoption of the 
condition for screening.
    Agenda: The meeting will include: (1) A discussion and vote on a 
systematic approach to evaluate the impact of adding newborn 
screening conditions on state public health systems; (2) a 
presentation on the impact of the rapid implementation of electronic 
health records on the Early Hearing Detection and Intervention State 
programs; (3) a discussion on a potential national infrastructure to 
conduct research on population-based screening; (4) a presentation 
on the impact of new CPT codes for molecular diagnostics on 
laboratories; and (5) updates from the Committee's Laboratory 
Standards and Procedures, Follow-up and Treatment, and Education and 
Training subcommittees. Tentatively, the Committee is expected to 
review and/or vote on a systematic approach to evaluate the impact 
of adding newborn screening conditions on state public health 
systems. This tentative vote does not involve any proposed addition 
of a condition to the Recommended Uniform Screening Panel.
    Agenda items are subject to change as necessary or appropriate. 
The agenda,

[[Page 20217]]

webinar information, Committee Roster, Charter, presentations, and 
other meeting materials are located on the Advisory Committee's Web 
site at http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
    Public Comments: Members of the public may present oral comments 
and/or submit written comments. Comments are part of the official 
Committee record. Public comment periods are tentatively scheduled 
for both May 29 and May 30, 2014. Advance registration is required 
to present oral comments and/or submit written comments at https://www.blsmeetings.net/ACHDNCMay2014. The registration deadline is 
Friday, May 2, 2014, 11:59 p.m. Eastern Time. Written comments must 
be received by the deadline in order to be included in the May 
meeting briefing book. Written comments should identify the 
individual's name, address, email, telephone number, professional or 
business affiliation, type of expertise (i.e., parent, researcher, 
clinician, public health, etc.), and the topic/subject matter of 
comments. To ensure that all individuals who have registered to make 
oral comments can be accommodated, the allocated time may be 
limited. Individuals who are associated with groups or have similar 
interests may be requested to combine their comments and present 
them through a single representative. No audiovisual presentations 
are permitted. For additional information or questions on public 
comments, please contact Lisa Vasquez, Maternal and Child Health 
Bureau, Health Resources and Services Administration; email: 
[email protected].
    For Further Information Contact: Anyone interested in obtaining 
other relevant information should contact Debi Sarkar, Maternal and 
Child Health Bureau, Health Resources and Services Administration, 
Room 18A-19, Parklawn Building, 5600 Fishers Lane, Rockville, 
Maryland 20857; email: [email protected].
    More information on the Advisory Committee is available at 
http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.

    Dated: April 3, 2014.
Jackie Painter,
Deputy Director, Division of Policy and Information Coordination.
[FR Doc. 2014-08079 Filed 4-10-14; 8:45 am]
BILLING CODE 4165-15-P